RxDoctor Payments Data

Lauren Hatcher, PA

Physician Assistant · Rome, GANPI 1013232073

Payments from drug & device makers

$2,940in general payments, 2019–2025

Across 181 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$376
  • Novo Nordisk$249
  • Amgen$230
  • Sumitomo Pharma America, Inc.$185
  • Amarin Pharma, Inc.$179
  • Boehringer Ingelheim$176
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$2,940100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,940 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$2,625
Medicare patients
22
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$70,871
OzempicSemaglutide34$31,840
TrulicityDulaglutide13$22,514
MounjaroTirzepatide18$21,417
MyrbetriqMirabegron28$19,431
XareltoRivaroxaban19$18,404
FarxigaDapagliflozin Propanediol20$17,419
Gabapentin60$1,732
Levothyroxine Sodium106$1,727
Omeprazole94$1,557
Amlodipine Besylate221$1,498
Famotidine145$1,480
Duloxetine Hcl43$1,227
Metoprolol Succinate62$1,170
Pravastatin Sodium66$1,100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$174$70,87162 claims
Lilly USA, LLCTrulicity, Mounjaro$170$43,93131 claims
Novo NordiskOzempic$249$31,84034 claims
Astellas Pharma US IncMyrbetriq$117$19,43128 claims
Johnson & JohnsonXarelto$13$18,40419 claims
AstraZenecaFarxiga$78$17,41920 claims
AbbVieSynthroid$376$88014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Rome

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →